Study of Intravenous VMX-C001 in Healthy Subjects and in Combination With Selected Direct Oral Anticoagulants in Healthy Older Subjects

NCT05152420 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Coagulation Disorder

Interventions

DRUG: VMX-C001
DRUG: Placebo
DRUG: Apixaban
DRUG: Rivaroxaban
DRUG: Edoxaban

Sponsor

VarmX B.V.